Clinical trial · Observational
Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT
the Use of 18F-FDG, 18F-DOPA and 68Ga-DOTATATE PET/CT in Patients With NETs That Are Potential Candidates for PRRT
NCT04622631CI-TRIAL-00048202unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
the investigators will follow up after patients with neuroendocrine tumors who undergo PRRT treatment and evaluate the response for treatment using PET/CT with different tracers
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neuroendocrine Tumors | Neuroendocrine Tumor | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- PRRT positive
- description
- patients who have good response to prrt treatment - the tumor and/or the metastatic disease show no uptake/activity on PET-CT scans
- label
- PRRT negative
- description
- no response to PRRT treatment
Primary outcomes (2)
- measure
- Number of participants with good response to Peptide Receptor Radionuclide Therapy (PRRT)
- timeFrame
- 7 months
- description
- patients who have clinical and radiological improvement (using RECIST CRITERIA )
- measure
- Number of participants with no response to Peptide Receptor Radionuclide Therapy (PRRT) treatment
- timeFrame
- 7 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patient with neuroendocrine tumor * eligible for PRRT Exclusion Criteria: * younger than 18 years old * pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.